BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Apogee Therapeutics, Inc. Announces Proposed $300 Million Underwritten Public Offering

  March 24, 2026

   · 

  5 min read
• Press Releases

  Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 23, 2026

  March 24, 2026

   · 

  1 min read
• Press Releases

  Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026

  March 24, 2026

   · 

  8 min read
• Press Releases

  Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p.m. ET

  March 24, 2026

   · 

  5 min read
• Press Releases

  Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results

  March 24, 2026

   · 

  1 min read
• Press Releases

  Globus Medical Announces Board Departure

  March 24, 2026

   · 

  3 min read
• Press Releases

  Salus Scientific Appoints Medical Device Executive Will Martin to Board of Directors

  March 24, 2026

   · 

  2 min read
• Press Releases

  Celosia Therapeutics Announces First Patient Dosed in Phase 1b Clinical Trial of CTx1000 in Amyotrophic Lateral Sclerosis

  March 24, 2026

   · 

  2 min read
• Press Releases

  Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases

  March 24, 2026

   · 

  11 min read
• Press Releases

  Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases

  March 24, 2026

   · 

  8 min read